| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Principal Financial Officer
1 company
Joseph Bratica last filed a Form 4 in December 2020, as Principal Financial Officer at SRPT. Joseph Bratica's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 8,140 shares of SRPT. The SRPT filings lean toward selling, a net 3,365 shares.
Joseph Bratica has 3 Form 4 filings on record from August 2020 to December 2020, all as Principal Financial Officer at Sarepta Therapeutics (SRPT), 2020.
The 6 reported transactions were 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $538K.
The largest open-market sale was 1,115 shares of SRPT at an average $165.00 on December 11, 2020, about $184K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2020 | SRPT Sarepta Therapeutics, Inc. | Principal Financial Officer | Sale+OE | 1,115 | $165.00 | $183,975.00 | -12.0% | |
| Dec 8, 2020 | SRPT Sarepta Therapeutics, Inc. | Principal Financial Officer | Sale+OE | 1,125 | $160.00 | $180,000.00 | -12.1% | |
| Aug 3, 2020 | SRPT Sarepta Therapeutics, Inc. | Principal Financial Officer | Sale+OE | 1,125 | $155.00 | $174,375.00 | -12.6% |